Primary Care Guidelines

Therapeutic Guidelines Menu

There has been a significant decrease in the morbidity and mortality of people living with HIV (PLWH) in the province of British Columbia since the introduction of potent antiretroviral treatment in 1996.

DOWNLOAD: Primary Care Guidelines (pdf)
Complete with commentary and references

The Primary Care Guidelines for the Management of HIV/AIDS in Adults in British Columbia, along with other therapeutic guidelines, have been developed by the BC-CfE to provide support for care and treatment programs for PLWH. These guidelines also respond to the need to expand HIV treatment to meet the goals of 90-90-90 in British Columbia and respond to requests from primary care providers in the community for HIV-specific guidelines.

Objectives

To provide consensus-based guidelines for the management of primary care for PLWH.

To provide practical and easily accessible information and resources for primary care providers of PLWH in the province of British Columbia.

WHAT’S NEW IN THE GUIDELINES

Toxoplasma Serology

Updated: November 2022

 

Table 3.3, Toxoplasma IgG serology, has been updated for agreement with the existing recommendations provided in the body of the Primary Care Guidelines. Toxoplasma IgG serology is indicated in all persons, regardless of CD4 cell count (Table 3.3). Previous versions stated toxoplasma IgG serology is indicated in persons with CD4 cell count <200 cells/mm3.

Scroll to Top

During the Canada Post strike, the following measures have been undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office.  (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During this time, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service.

Start typing and press enter to search